A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

Clinical trial NCT05873686 · RECRUITING

Trial details

NCT number: NCT05873686
Sponsor: Nuvectis Pharma, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor NSCLC (Non-small Cell Lung Cancer)Renal Cancer Mesothelioma Non-Small Cell Squamous Lung Cancer Non-small Cell Lung Adenocarcinoma

Start date: 2023-10-26
Primary completion: 2027-03-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.